CEL-SCI Corporation CVM 深 滬
已收盤 02-06 16:00:00 美东时间
5.00
+0.100
+2.04%
華盛通- 最 高5.23
- 今 開4.88
- 成交量 4.04万股
- 最 低 4.88
- 昨 收 4.90
- 總市值 4204.37万
- 52周最高 20.409
- 市盈率 靜 --
- 換手率 0.48%
- 52周最低 1.98
- 委 比 34.23%
- 總股本 840.87万
- 歷史最高 1425.00
- 量 比 0.54
- 振 幅 7.14%
- 歷史最低 4.66
- 每 手 1
- 風險率 2.72%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Geert R. Kersten, CEO, Reports Acquisition of CEL-SCI Corporation Common Shares
Geert R. Kersten, CEO, Reports Acquisition of CEL-SCI Corporation Common Shares Geert R. Kersten, Chief Executive Officer of CEL-SCI Corporation, has reported the acquisition of common shares of CEL-SCI Corporation according to a recent regulatory filing. The full filing can be accessed through the
01-26 21:24
Cel-Sci reports FY results
Cel-Sci press release (CVM): FY research and development expenses were $15.9 million, which decreased by approximately $2.3 million, or 13%, compared to the year ended September 30, 2024. Net loss ava...
2025-12-30 12:34
Reported Saturday, BridgeBio's Attruby/BEYONTTRA Reports Significant 42-Month CV Mortality Reduction In ATTRibute-CM Open Label Extension
- Acoramidis demonstrated a significant reduction in risk of CVM through 42 months post-randomization, with a 44% hazard reduction, setting a new standard for CVM outcomes for patients with ATTR-CM- Acoramidis also
2025-09-02 15:50
CEL-SCI股价重挫逾30%，此前宣布完成1000万美元公开发行定价
美股周四早盘，生物技术公司CEL-SCI（CVM）股价重挫30.44%，此前该公司宣布完成1000万美元公开发行定价，以每股9.00美元的价格出售1111...
2025-08-28 22:51
Why Snowflake Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Shares of Snowflake Inc. (NYSE:SNOW) rose sharply in pre-market trading after t...
2025-08-28 17:48
Why Is CEL-SCI Stock Crashing After-Hours?
CEL-SCI's shares dropped 38.19% after announcing a $10 million public offering priced below market value to fund its cancer immunotherapy development.
2025-08-28 15:12
CEL-SCI shares drop on proposed public offering
CEL-SCI Corporation (NYSE:CVM) said on Wednesday that it intends to offer to sell shares of its common stock in a best-efforts public offering. All of the shares of common stock are being offered by...
2025-08-28 05:32
CEL-SCI Announces Proposed Public Offering; No Size Or Amount Disclosed
CEL-SCI Corporation ("CEL-SCI" or the "Company") (NYSE:CVM), a clinical stage cancer immunotherapy company,today announced that it intends to offer to sell shares of its common stock (and/or pre-funded warrants
2025-08-28 05:26
CEL-SCI Q3 EPS $(1.36) Up From $(4.18) YoY
CEL-SCI (AMEX:CVM) reported quarterly losses of $(1.36) per share. This is a 67.46 percent increase over losses of $(4.18) per share from the same period last year.
2025-08-14 22:47
CEL-SCI Signs MOU With Leading Saudi Pharma; Breakthrough Medicine Designation Filed For Multikine With SFDA, Eyes MENA Expansion
Memorandum of Understanding (MOU) signed with a leading Saudi Arabian pharma company which submitted the Breakthrough Medicine Designation to the Saudi Food and Drug Authority (SFDA)Increasing interest in CEL-SCI from
2025-08-13 21:16
